Strategic Operations, Inc. v. Joseph et al

Filing 15

ORDER Granting Defendants' 10 Motion to Dismiss for Failure to State a Claim. Signed by Judge Janis L. Sammartino on 8/13/2018. (mpl)

Download PDF
1 2 3 4 5 6 7 8 9 UNITED STATES DISTRICT COURT 10 SOUTHERN DISTRICT OF CALIFORNIA 11 12 STRATEGIC OPERATIONS, INC., Case No.: 17-CV-1539-JLS (NLS) Plaintiff, 13 14 v. ORDER GRANTING DEFENDANTS’ MOTION TO DISMISS 15 BREA K. JOSEPH, et al., (ECF No. 10) Defendants. 16 17 18 Presently before the Court is Defendants Brea K. Joseph and KBZ FX, Inc.’s Motion 19 to Dismiss, (“MTD,” ECF No. 10). Also before the Court is Plaintiff Strategic Operations, 20 Inc.’s Response in Opposition to the Motion, (“Opp’n,” ECF No. 11), and Defendants’ 21 Reply in Support of the Motion, (“Reply,” ECF No. 13). The Court vacated oral argument 22 on the Motion and took the matter under submission without oral argument. (ECF No. 12.) 23 After considering the Parties’ arguments and the law, the Court rules as follows. BACKGROUND 24 25 Plaintiff Strategic Operations, Inc. (“StOps”) filed a Complaint against Brea Joseph, 26 Kasey Erokhin, KBZ FX, and KBX FX, Inc. (“Compl.,” ECF No. 1.) Plaintiff brings 27 causes of action of patent infringement, breach of nondisclosure agreement, and unfair 28 competition. 1 17-CV-1539-JLS (NLS) 1 Plaintiff is the executive licensee of United States Patent No. 8,840,403 (“the ’403 2 patent”). (Id. ¶ 17.) The ’403 patent “pertains to devices and methods for simulating 3 realistic-looking, dynamic injuries that a person may receive during a traumatic event.” 4 (Id. ¶ 18.) For example, the devices claimed in the patent “can be worn by ‘role players’ 5 during a simulated traumatic event to mimic a plurality of different combat-related 6 bleeding wounds and internal injuries and allow first responders to perform medical 7 treatment on the same.” (Id.) 8 Defendants Joseph and Erokin were previously employed by Plaintiff as injury 9 simulation makeup artists. (Id. ¶ 19.) During their employment, Joseph and Erokin were 10 exposed to role players wearing and using the “Cut Suit,” which is one of Plaintiff’s human- 11 worn trauma and medical training products. (Id. ¶¶ 19–20.) The “Cut Suit” embodies or 12 uses one or more inventions claimed in the ’403 patent. (Id. ¶ 19.) Plaintiff previously 13 sued Joseph and Erokin for breach of loyalty, interference with employment relationship, 14 and violation of the Uniform Trade Secrets Act. (Id. ¶ 22.) As part of the settlement 15 agreement in that case, “Joseph and Erokhin agreed to refrain from using Strategic 16 Operations’ confidential and proprietary technology and trade secret information for any 17 purpose.” (Id. ¶ 23.) 18 In June 2011, Joseph and Erokin left Plaintiff’s company and formed KBZ FX which 19 is “a special effects medical training support system,” which provides “injury simulations.” 20 (Id. ¶ 24.) One of KBZ FX’s products is a “trauma training kit” (hereinafter, “TTK”), 21 which is “a human body replica suit used to perform actual treatments on for medical 22 training.” (Id. ¶ 25.) Plaintiff alleges the TTK infringes the ’403 patent. Plaintiff also 23 brings causes of action for breach of nondisclosure agreement and unfair competition. 24 Finally, Plaintiff alleges Defendants have failed to respect the corporate form of KBZ FX. 25 Defendants Joseph and KBZ FX, Inc. move to dismiss Plaintiff’s infringement claim 26 27 28 and alter ego allegations pursuant to Federal Rule of Civil Procedure 12(b)(6). LEGAL STANDARD Federal Rule of Civil Procedure 12(b)(6) permits a party to raise by motion the 2 17-CV-1539-JLS (NLS) 1 defense that the complaint “fail[s] to state a claim upon which relief can be granted,” 2 generally referred to as a motion to dismiss. The Court evaluates whether a complaint 3 states a cognizable legal theory and sufficient facts in light of Federal Rule of Civil 4 Procedure 8(a), which requires a “short and plain statement of the claim showing that the 5 pleader is entitled to relief.” 6 allegations,’ . . . it [does] demand more than an unadorned, the-defendant-unlawfully- 7 harmed-me accusation.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quoting Bell Atl. 8 Corp. v. Twombly, 550 U.S. 544, 555 (2007)). In other words, “a plaintiff’s obligation to 9 provide the ‘grounds’ of his ‘entitle[ment] to relief’ requires more than labels and 10 conclusions, and a formulaic recitation of the elements of a cause of action will not do.” 11 Twombly, 550 U.S. at 555 (citing Papasan v. Allain, 478 U.S. 265, 286 (1986)). A 12 complaint will not suffice “if it tenders ‘naked assertion[s]’ devoid of ‘further factual 13 enhancement.’” Iqbal, 556 U.S. at 677 (citing Twombly, 550 U.S. at 557). Although Rule 8 “does not require ‘detailed factual 14 In order to survive a motion to dismiss, “a complaint must contain sufficient factual 15 matter, accepted as true, to ‘state a claim to relief that is plausible on its face.’” Id. (quoting 16 Twombly, 550 U.S. at 570); see also Fed. R. Civ. P. 12(b)(6). A claim is facially plausible 17 when the facts pled “allow the court to draw the reasonable inference that the defendant is 18 liable for the misconduct alleged.” Iqbal, 556 U.S. at 677 (citing Twombly, 550 U.S. at 19 556). That is not to say that the claim must be probable, but there must be “more than a 20 sheer possibility that a defendant has acted unlawfully.” Id. Facts “‘merely consistent 21 with’ a defendant’s liability” fall short of a plausible entitlement to relief. Id. (quoting 22 Twombly, 550 U.S. at 557). Further, the Court need not accept as true “legal conclusions” 23 contained in the complaint. Id. This review requires context-specific analysis involving 24 the Court’s “judicial experience and common sense.” Id. at 678 (citation omitted). 25 “[W]here the well-pleaded facts do not permit the court to infer more than the mere 26 possibility of misconduct, the complaint has alleged—but it has not ‘show[n]’—‘that the 27 pleader is entitled to relief.’” Id. 28 /// 3 17-CV-1539-JLS (NLS) 1 2 ANALYSIS I. Patent Infringement 3 Plaintiff attached as an exhibit to its Complaint screenshots of KBZ FX’s website. 4 The first image is one of a skeleton with “TTK: Trauma Training Kit” written on top of the 5 image. (Compl. 29.)1 The text above the image provides: Introducing KBZ FX’s Trauma Training Kit (TTK). The TTK is an effective and economical way to train your First Responders, Medical Professionals, and Combat Medics on live Role Players. In the past, in-field medical procedure training has been limited to practicing on rescue dummies and mannequins with limited audio and visual feedback resulting in a lack of realism. The TTK is a wearable chest prosthetic as well as a line of limb attachments that are worn by a live person that can give immediate realistic feedback in real time training scenarios. Please contact us (KBZFXmakeup1@gmail.com) for options and pricing. 6 7 8 9 10 11 12 13 (Id.) Below are more images of products, which appear to be part of the TTK. These 14 images include an image of a “skin vest,” an image of “rib cage and organs” depicting 15 simulated organs, followed by multiple other images of “attachments” which are products 16 for all body parts. (Id. at 30–43.) 17 Defendants’ main argument is that these images from the website do not depict a 18 product made, used or sold by KBZ but reflect “old marketing materials that were briefly 19 posted on KBZ’s website from January through April[] 2017 purely for marketing 20 purposes.” (MTD 6.) KBZ’s actual product “lacks an outer raiment having at least one 21 fluid reservoir (as required by the ’403 patent) and lacks a cavity for containing prosthetic 22 internal human organs (as required by the ’403 patent).” (Id. at 6–7.) For these reasons, 23 Defendants argue they do not infringe the ’403 patent. A. Attached Declarations 24 25 Defendants state they have never sold or offered for sale any infringing product, and 26 include declarations by Ms. Joseph to this effect. (ECF Nos. 10-2; 13-1.) In a footnote, 27 28 1 Pin citations refer to the CM/ECF page numbers electronically stamped at the top of each page. 4 17-CV-1539-JLS (NLS) 1 Defendants ask the Court to consider the declarations when analyzing the motion to 2 dismiss. (MTD 6 n.1.) 3 As a general rule, “a district court may not consider any material beyond the 4 pleadings in ruling on a Rule 12(b)(6) motion.” Lee v. City of Los Angeles, 250 F.3d 668, 5 688 (9th Cir. 2001). The only exceptions to this rule are for (1) material which is submitted 6 with or necessarily relied on in the complaint and (2) matters of public record. Id. at 688– 7 89. The attached declarations are not pleadings, see Fed. R. Civ. P. 7(a), were not attached 8 to or relied on in the Complaint, nor are they a matter of public record. To consider the 9 declarations would convert the Motion to Dismiss into a motion for summary judgment, 10 and the Court declines to do so at this stage. Therefore, the Court cannot consider the 11 declarations here.2 See Cooper v. Pickett, 137 F.3d 616, 623 (9th Cir. 1997) (refusing to 12 consider declarations submitted in support of a motion to dismiss because they were not 13 “referenced in the complaint” or matters of public record). B. “Offer for Sale” Analysis 14 15 An act of direct patent infringement occurs when an entity “without authority makes, 16 uses, offers to sell, or sells any patented invention, within the United States or imports into 17 the United States any patented invention during the term of the patent.” 35 U.S.C. § 271(a). 18 The issue here is whether Plaintiff has sufficiently alleged Defendants offered for sale an 19 infringing product. The statute broadly defines “offer for sale” or “offer to sell” as “that in 20 which the sale will occur before the expiration of the term of the patent.” 35 U.S.C. 21 § 271(i). The Federal Circuit has held an “offer to sell” occurs when the alleged infringer 22 sends “a description of the allegedly infringing merchandise and the price at which it can 23 be purchased.” 3D Sys., Inc. v. Aarotech Labs, Inc., 160 F.3d 1373, 1379 (Fed. Cir. 1998). 24 The Federal Circuit later revisited the issue and defined “‘offer to sell’ liability according 25 26 For the same reasons, the Court does not consider the declaration and exhibits attached to Plaintiff’s Opposition. (ECF No. 11-1.) See also Frenzel v. AliphCom, 76 F. Supp. 3d 999, 1009 (N.D. Cal. 2014) (noting that “[i]t is axiomatic that the complaint may not be amended by the briefs in opposition to a motion to dismiss”). 2 27 28 5 17-CV-1539-JLS (NLS) 1 to the norms of traditional contractual analysis.” Rotec Indus., Inc. v. Mitsubishi Corp., 2 215 F.3d 1246, 1254–55 (Fed Cir. 2000). The next year, the Federal Circuit reaffirmed 3 this general definition after interpreting the Supreme Court’s opinion in Pfaff v. Wells 4 Electronics, Inc., 525 U.S. 55 (1998). See Group One, Ltd. v. Hallmark Cards, Inc., 254 5 F.3d 1041, 1046 (Fed. Cir. 2001). The court held the language from Pfaff “strongly 6 suggests that the offer must meet the level of an offer for sale in the contract sense, one 7 that would be understood as such in the commercial community. Such a reading leaves no 8 room for ‘activity which does not rise to the level of a formal “offer” under contract law 9 principles.’” Id. at 1046–47. The court “note[d] in passing that contract law traditionally 10 recognizes that mere advertising and promoting of a product may be nothing more than an 11 invitation for offers, while responding to such an invitation may itself be an offer.” Id. at 12 1048 (citing Restatement (Second) of Contracts § 26 (1981)). 13 Here, accepting all Plaintiff’s allegations as true, and even disregarding Defendants’ 14 declarations, the Court finds the posting of TTK, as depicted exhibit 2 to the Complaint, is 15 not an “offer for sale.” There is no information on pricing of the product; instead the post 16 specifically invites the consumer to send an email to request pricing information. This is 17 merely an “invitation for offers.” Id. The posting is not sufficiently alleged to be an “offer 18 for sale.” 19 The Complaint specifically alleges “[d]espite being informed of StOps’ ’403 Patent 20 and StOps concerns that the TTK infringes the ‘403 Patent, Joseph, Erokhin, KBZ FX, and 21 now KBZ FX, INC. nevertheless continue to make, use, sell, and offer for sale, the TTK.” 22 (Compl. ¶ 29.) But this is merely a conclusory allegation, and, without the attached exhibit, 23 has no support.3 Because Plaintiff has failed to sufficiently plead an element of patent 24 infringement, the Court GRANTS Defendants’ Motion to Dismiss this claim. 25 26 3 27 28 Further, Defendants admit they do make a product, which is not the product depicted on the website (TTK), but argue that it is not infringing. (MTD 6 (referring to “the actual KBZ product”).) Plaintiff has not alleged that this product is sold or offered for sale by Defendants, thus the Court does not analyze this unspecified product. 6 17-CV-1539-JLS (NLS) 1 2 3 4 5 6 7 8 9 10 II. Alter Ego Allegations Plaintiff alleges: On information and belief, Defendants Erokhin, Joseph, KBZ FX, and KBZ FX, Inc., and each of them, among other things: (a) commingled funds and other assets; (b) treated corporate assets as personal assets; (c) failed to observe corporate formalities and adhere to corporate bylaws; (d) used the corporate structure as a subterfuge for illegal transactions; and (e) were undercapitalized; and, therefore, there exists a unity of interest and ownership between each of these named Defendants such that Defendant KBZ FX, Inc. is the Alter Ego of Defendants Erokhin, Joseph, KBZ FX and that any separateness between them has ceased to exist and that to adhere to the fiction of their separate identities would result in injustice. 11 12 (Compl. ¶ 9.) Defendants move to dismiss these allegations because they are not pled with 13 particularity. (MTD 8.) 14 “Conclusory allegations of ‘alter ego’ status are insufficient to state a claim.” 15 Neilson v. Union Bank of Cal., N.A., 290 F. Supp. 2d 1101, 1116 (C.D. Cal. 2003). “Rather, 16 a plaintiff must allege specifically both the elements of alter ego liability, as well as facts 17 supporting each.” Id. These elements are: “(1) such a unity of interest and ownership 18 exists that the personalities of the corporation and individual are no longer separate, and 19 (2) an inequitable result will follow if the acts are treated as those of the corporation alone.” 20 RRX Indus., Inc. v. Lab–Con, Inc., 772 F.2d 543, 545–46 (9th Cir. 1985). In analyzing the 21 doctrine, courts consider factors such as: 22 23 24 25 commingling of funds and other assets of the two entities, the holding out by one entity that it is liable for the debts of the other, identical equitable ownership in the two entities, use of the same offices and employees, and use of one as a mere shell or conduit for the affairs of the other. 26 Sonora Diamond Corp. v. Superior Court, 83 Cal. App. 4th 523, 538–39 (Ct. App. 2000) 27 (internal quotations omitted). 28 For the first alter ego element, Plaintiff merely alleges the basic Sonora factors: 7 17-CV-1539-JLS (NLS) 1 mixing funds, lack of corporate formalities, and undercapitalization. 2 Plaintiff provides no facts in support of these allegations. For the second alter ego element, 3 Plaintiff alleges “to adhere to the fiction of [Defendants’] separate identities would result 4 in injustice.” (Compl. ¶ 9.) Again, this is conclusory, has no support, and Plaintiff has not 5 alleged how or why injustice would result if the corporate veil is not pierced. It is also 6 unclear to which cause of action the alter ego allegations apply, and why piercing the 7 corporate veil is necessary for an equitable result. Plaintiff has not sufficiently pled either 8 element of alter ego and the Court GRANTS Defendants’ Motion to Dismiss the alter ego 9 allegations. 10 (Compl. ¶ 9.) CONCLUSION 11 For the foregoing reasons, the Court GRANTS Defendants’ Motion to Dismiss. The 12 Court GRANTS Plaintiff leave to amend its Complaint. Plaintiff MAY file an amended 13 complaint on or before thirty (30) days of the electronic docketing of this Order. Should 14 Plaintiff choose not to file an amended complaint by this time, this case will proceed on 15 the remaining allegations. 16 17 IT IS SO ORDERED. Dated: August 13, 2018 18 19 20 21 22 23 24 25 26 27 28 8 17-CV-1539-JLS (NLS)

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?